Metabolic Changes in Patients With Chronic Cardiopulmonary Disease
NCT ID: NCT02550808
Last Updated: 2015-09-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
400 participants
OBSERVATIONAL
2012-03-31
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nutritional Status in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease
NCT03709498
Systemic Consequences and Comorbidities in Mild/Moderate Chronic Obstructive Pulmonary Disease (COPD), Time for Action!
NCT01314807
Assessment of Risk in Chronic Airways Disease Evaluation
NCT01656421
Endothelial Dysfunction and Chronic Obstructive Pulmonary Disease
NCT02092675
Late Respiratory Consequences of SARS-CoV-2 Pneumonia
NCT05812196
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Heart failure
No interventions assigned to this group
Chronic obstructive pulmonary disease
No interventions assigned to this group
Chronic kidney disease
No interventions assigned to this group
Malignancy
No interventions assigned to this group
Controls
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Ljubljana
OTHER
General Hospital Murska Sobota
OTHER
Maastricht University
OTHER
General and Teaching Hospital Celje
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mitja Lainscak
Professor of Internal Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
General Hospital Celje
Celje, , Slovenia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ML-MTB-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.